Laura Pat Svetkey, MD

Professor of Medicine
Director of Clinical Research
Vice-chair for Faculty Development & Diversity in the Department of Medicine
Campus mail Duke Box 3487, Durham, NC 27710
Phone (919) 660-6626
Email address svetk001@mc.duke.edu

Laura P. Svetkey, MD MHS is Professor of Medicine, Director of the Duke Hypertension Center, Director of Clinical Research at the Sarah W. Stedman Nutrition and Metabolism Center, Vice Chair for Faculty Development and Diversity in the Department of Medicine. She is also the Director of Duke’s CTSA internal career development award program (KL2).She is a faculty member of the Duke Molecular Physiology Institute (DMPI) and the Cardiovascular Research Center (CVRC). She is co-Director of the Clinical and Translational Core of the Duke O’Brien Center for Kidney Research (DOCK).

Dr. Svetkey has over 30 years of experience in the investigation of hypertension, obesity, and related areas, conducting NIH-sponsored clinical research ranging from behavioral intervention trials to metabolomics and genetics, with a consistent focus on prevention, non-pharmacologic intervention, health disparities and minority health. Her research has affected national guidelines, having served on the 2013 national Hypertension Guideline Panel (JNC) and the Lifestyle Guideline Working Group. She is a member of the Association of American Physicians (AAP).

Dr. Svetkey is Vice Chair for Faculty Development and Diversity in the Department of Medicine.  In this role she implements a wide range of programs to enhance the experience and advancement of faculty and trainees, with particular emphasis on under-represented minorities and women.

Education and Training

  • Fellow in General Internal Medicine, Medicine, Duke University, 1982 - 1983
  • Resident in Medicine, Medicine, Montefiore Medical Center, 1980 - 1982
  • Intern in Medicine, Medicine, Montefiore Medical Center, 1979 - 1980
  • M.D., Harvard University, 1979

Publications

Sun, B, Williams, JS, Svetkey, LP, Kolatkar, NS, and Conlin, PR. "Beta2-adrenergic receptor genotype affects the renin-angiotensin-aldosterone system response to the Dietary Approaches to Stop Hypertension (DASH) dietary pattern." Am J Clin Nutr 92, no. 2 (August 2010): 444-449.

PMID
20519561
Full Text

Szczech, LA, Menezes, P, Byrd Quinlivan, E, van der Horst, C, Bartlett, JA, and Svetkey, LP. "Microalbuminuria predicts overt proteinuria among patients with HIV infection." HIV Med 11, no. 7 (August 2010): 419-426.

PMID
20059571
Full Text

Funk, KL, Stevens, VJ, Appel, LJ, Bauck, A, Brantley, PJ, Champagne, CM, Coughlin, J, Dalcin, AT, Harvey-Berino, J, Hollis, JF, Jerome, GJ, Kennedy, BM, Lien, LF, Myers, VH, Samuel-Hodge, C, Svetkey, LP, and Vollmer, WM. "Associations of internet website use with weight change in a long-term weight loss maintenance program. (Published online)" J Med Internet Res 12, no. 3 (July 27, 2010): e29-.

PMID
20663751
Full Text

Rocha-Goldberg, MDP, Corsino, L, Batch, B, Voils, CI, Thorpe, CT, Bosworth, HB, and Svetkey, LP. "Hypertension Improvement Project (HIP) Latino: results of a pilot study of lifestyle intervention for lowering blood pressure in Latino adults." Ethn Health 15, no. 3 (June 2010): 269-282.

PMID
20379894
Full Text

Reed, SD, Li, Y, Oddone, EZ, Neary, AM, Orr, MM, Grubber, JM, Graham, FL, Olsen, MK, Svetkey, LP, Dolor, RJ, Powers, BJ, Adams, MB, and Bosworth, HB. "Economic evaluation of home blood pressure monitoring with or without telephonic behavioral self-management in patients with hypertension." Am J Hypertens 23, no. 2 (February 2010): 142-148.

PMID
19927132
Full Text

Svetkey, LP, Pollak, KI, Yancy, WS, Dolor, RJ, Batch, BC, Samsa, G, Matchar, DB, and Lin, P-H. "Hypertension improvement project: randomized trial of quality improvement for physicians and lifestyle modification for patients." Hypertension 54, no. 6 (December 2009): 1226-1233.

PMID
19920081
Full Text

Bosworth, HB, Olsen, MK, Grubber, JM, Neary, AM, Orr, MM, Powers, BJ, Adams, MB, Svetkey, LP, Reed, SD, Li, Y, Dolor, RJ, and Oddone, EZ. "Two self-management interventions to improve hypertension control: a randomized trial." Ann Intern Med 151, no. 10 (November 17, 2009): 687-695.

PMID
19920269
Full Text

Svetkey, LP, Pollak, KI, Yancy, WS, Dolor, RJ, Batch, BC, Samsa, G, Matchar, DB, and Lin, P-H. "Hypertension Improvement Project (HIP): Randomized Trial of Quality Improvement for Physicians and Lifestyle Modification for Patients." November 3, 2009.

Scholars@Duke

Shah, SH, Crosslin, DR, Nelson, S, Haynes, C, Boling, CL, Bain, J, Muehlbauer, M, Stevens, RD, Brantley, PJ, Stevens, V, Hollis, JF, Appel, LJ, Lien, L, Newgard, CB, and Svetkey, LP. "Metabolomic Profiles Are Associated With Baseline Insulin Resistance and Improvement in Insulin Resistance With Weight Loss in the WLM Trial." November 3, 2009.

Scholars@Duke

Sun, B, Williams, J, Conlin, PR, and Svetkey, LP. "beta 2-Adrenergic Receptor Genotype Affects the Renin-Angiotensin-Aldosterone System Response to the DASH Dietary Pattern." HYPERTENSION 54, no. 4 (October 2009): E46-E46.

Scholars@Duke

Pages